title: Ube2l3 gene expression is modulated by activation of the aryl hydrocarbon receptor: implications for p53 ubiquitination.
abstract: Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a halogenated aromatic hydrocarbon and environmental contaminant, results in several deleterious effects, including fetal malformation and cancer. These effects are mediated by the aryl hydrocarbon receptor (AhR), a ligand-activated receptor that regulates the expression of genes encoding xenobiotic-metabolizing enzymes. Several reports suggest that AhR function is beyond the adaptive chemical response. In the present study, we analyzed and compared gene expression profiles of C57BL/6N wild-type (WT) and Ahr-null mice. DNA microarray and quantitative RT-PCR analyses revealed changes in the expression of genes involved in the ubiquitin-proteasome system (UPS). UPS has an important role in cellular homeostasis control and dysfunction of this pathway has been implicated in the development of several human pathologies. Protein ubiquitination is a multi-step enzymatic process that regulates the stability, function, and/or localization of the modified proteins. This system is highly regulated post-translationally by covalent modifications. However, little information regarding the transcriptional regulation of the genes encoding ubiquitin (Ub) proteins is available. Therefore, we investigated the role of the AhR in modulation of the UPS and regulation of Ube2l3 transcription, an E2 ubiquitin-conjugating enzyme, as well as the effects on p53 degradation. Our results indicate that AhR inactivation decreases on liver proteasome activity, probably due to a down-regulation on the expression of several proteasome subunits. On the other hand, AhR activation increases Ube2l3 mRNA and protein levels by controlling Ube2l3 gene expression, resulting in increased p53 ubiquitination and degradation. In agreement with this, induction of apoptosis was attenuated by the AhR activation.
authors.affiliation: Departamento de Toxicología, CINVESTAV-IPN, Zacatenco. México D.F., Av. IPN 2508, C.P. 07360, Mexico.
authors.forename: O D
authors.initials: OD
authors.lastname: Reyes-Hernández
authors.forename: A
authors.initials: A
authors.lastname: Mejía-García
authors.forename: E M
authors.initials: EM
authors.lastname: Sánchez-Ocampo
authors.forename: M A
authors.initials: MA
authors.lastname: Cabañas-Cortés
authors.forename: P
authors.initials: P
authors.lastname: Ramírez
authors.forename: L
authors.initials: L
authors.lastname: Chávez-González
authors.forename: F J
authors.initials: FJ
authors.lastname: Gonzalez
authors.forename: G
authors.initials: G
authors.lastname: Elizondo
mesh_terms: D000818:Animals; D001483:Base Sequence; D005786:Gene Expression Regulation; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008969:Molecular Sequence Data; D011401:Promoter Regions, Genetic / Q000502:physiology*; D018336:Receptors, Aryl Hydrocarbon / Q000378:metabolism*; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*; D025801:Ubiquitin / Q000096:biosynthesis / Q000378:metabolism; D054875:Ubiquitination / Q000502:physiology*
chemical_list: D018336:Receptors, Aryl Hydrocarbon; D016159:Tumor Suppressor Protein p53; D025801:Ubiquitin